Fusion of SPECT with computed tomography or magnetic resonance for the interpretation of abnormal tracer uptake Utilidad clínica de la fusión SPECT/CT con marcadores externos en patología oncológica
Author
dc.contributor.author
Aqueveque A, Carolina
Author
dc.contributor.author
González Espinoza, Patricio
Author
dc.contributor.author
Gutiérrez B, Daniela
Author
dc.contributor.author
Jaimovich, Rodrigo
Author
dc.contributor.author
Díaz P, Juan Carlos
Author
dc.contributor.author
Csendes González, Paula
Author
dc.contributor.author
Orellana P, Patricia
Author
dc.contributor.author
Lavados Montes, Hugo
Author
dc.contributor.author
Alliende G, Isabel
Author
dc.contributor.author
Araya L, Sandra
Admission date
dc.date.accessioned
2019-03-11T12:54:15Z
Available date
dc.date.available
2019-03-11T12:54:15Z
Publication date
dc.date.issued
2007
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 135, Issue 6, 2018, Pages 725-734
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164376
Abstract
dc.description.abstract
Background: Interpretation of abnormal foci with high tracer uptake may require morphological correlation. Fusion of functional images obtained by single photon emission computed tomography (SPECT) and anatomical images obtained by computed tomography (CT) or magnetic resonance (RM) allows an integrated comprehension of complementary information. Aim: To demonstrate that SPECT/CT fusion with external markers is useful in clinical practice to clarify the location and pathological meaning of questionable foci. Material and methods: Thirty four pairs of images from separate equipments (31 SPECT/CT and 3 SPECT/RM) pertaining to 29 patients, were fused. Fifty one foci of abnormal tracer uptake of uncertain pathological meaning were analyzed. These were classified before and after the fusion as probably malignant or probably benign. Results: Seventy percent of patients had a differentiated thyroid carcinoma. The fusion localized 100% of foci. Nine percent had a normal and 26% an abnormal ana
Fusion of SPECT with computed tomography or magnetic resonance for the interpretation of abnormal tracer uptake Utilidad clínica de la fusión SPECT/CT con marcadores externos en patología oncológica